-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: What are the advantages of the GVHD experiment platform?
Author:
InnoModels
Release time:
2024-03-19
In the field of modern medicine, with the progress of science and technology and the depth of research, we have gradually recognized the complexity and diversity of many diseases. Among them, Graft-versus-Host Disease (GVHD), as a common immune disease, has been the focus of attention of the medical community. In order to study the pathogenesis of GVHD more deeply and explore effective treatment methods, the GVHD experimental platform of InnoModels Biotechnology has emerged as an important tool in the field of scientific research.
1. Highly simulate the human environment
The GVHD experimental platform of InnoModels Biotechnology can highly simulate the internal environment of the human body, providing researchers with near-real experimental conditions. By simulating the immune system, tissue structure and physiological responses of different individuals, the platform can more accurately reflect the occurrence and development of GVHD in the human body, providing strong support for disease research.
2. Diversified experimental methods
The platform integrates a variety of experimental tools, such as cell culture, molecular biology, immunological analysis, etc., providing researchers with comprehensive and detailed research tools. Researchers can choose appropriate experimental tools according to different experimental needs, so as to better analyze the pathogenesis of GVHD.
3. Accurate drug screening and evaluation
InnoModels Bio's GVHD experimental platform can not only simulate the disease process, but also accurately screen and evaluate potential therapeutic drugs. Through this platform, researchers can quickly screen drugs with therapeutic potential and evaluate their efficacy and safety, providing strong support for clinical drug development.

4. Efficient data integration and analysis
In modern biomedical research, data integration and analysis has become an essential skill. Equipped with an advanced data processing system, the GVHD experimental platform can efficiently integrate and analyze the experimental data, helping researchers to find out the key information in the experiments more quickly and promote the scientific research process.
5. Promote the transformation of scientific research results
InnoModels' GVHD experimental platform not only provides researchers with powerful research tools, but also actively promotes the transformation of research results. Through cooperation with medical institutions and pharmaceutical companies, the platform applies research results to clinical practice, providing patients with more effective treatments and promoting the progress of the medical field.
In summary, the GVHD experimental platform of InnoModels Biotechnology has become a powerful tool for researching the pathogenesis and therapeutic methods of GVHD with its advantages of highly simulating the human environment, diversified experimental methods, accurate drug screening and evaluation, efficient data integration and analysis, and promotion of the transformation of scientific research results. In the future, with the advancement of science and technology and in-depth research, the platform is expected to bring more breakthroughs and discoveries in the field of medicine and make greater contributions to human health.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd